Health care industry

Health care industry

Amgen Announces Pivotal Phase 3 Results Demonstrating Panitumumab's Efficacy in Metastatic Colorectal Cancer

Amgen today announced pivotal Phase 3 results demonstrating that panitumumab significantly improved progression-free survival and disease control in metastatic colorectal cancer patients who had failed standard chemotherapy. The results were presented at the 97th Annual Meeting of the American Association for Cancer Research. Panitumumab reduced the rate of disease progression